Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry

BACKGROUND: Interleukin-6 receptor antagonists (IL-6RAs) and steroids are emerging immunomodulatory therapies for severe and critical coronavirus disease (COVID-19). In this preliminary report, we aim to describe the epidemiology, clinical characteristics, and outcomes of adult critically ill COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Amer, Marwa, Kamel, Ahmed M., Bawazeer, Mohammed, Maghrabi, Khalid, Butt, Abid, Dahhan, Talal, Kseibi, Eiad, Khurshid, Syed Moazzum, Abujazar, Mohammed, Alghunaim, Razan, Rabee, Muath, Abualkhair, Maal, Al-Janoubi, Ali, AlFirm, Abeer Turki, Gajic, Ognjen, Walkey, Allan J., Mosier, Jarrod M., Zabolotskikh, Igor Borisovich, Gavidia, Oscar Y., Teruel, Santiago Yus-, Bernstein, Michael A., Boman, Karen, Kumar, Vishakha K., Bansal, Vikas, Kashyap, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487342/
https://www.ncbi.nlm.nih.gov/pubmed/34600589
http://dx.doi.org/10.1186/s40001-021-00591-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487342/
https://www.ncbi.nlm.nih.gov/pubmed/34600589
http://dx.doi.org/10.1186/s40001-021-00591-x

Ejemplares similares